Concepedia

Luca Paruzzo

LP

Statistics

Publications

13

Citations

672

H-Index

11

Active since

2021

Affiliations

University of Pennsylvania(Current)

Hospital of the University of Pennsylvania

UPMC Hillman Cancer Center

Parker Institute for Cancer Immunotherapy

University of Turin

Luca Paruzzo is an author at University of Pennsylvania specializing in immunotherapy, cancer immunology, and oncology.

ORCID

Publications per year

2021–2025

13

Publications

13

T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy

Guido Ghilardi, Joseph A. Fraietta, James N. Gerson et al. · Nature Medicine · 2024 · 256 citations

, , +16

Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure

Jakub Svoboda, Daniel J. Landsburg, James N. Gerson et al. · New England Journal of Medicine · 2025 · 93 citations

, , +17

EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models

Patrizia Porazzi, Siena Nason, Alberto Carturan et al. · Cancer Cell · 2025 · 49 citations

, , +11

CD5 deletion enhances the antitumor activity of adoptive T cell therapies

Ruchi P. Patel, Guido Ghilardi, Yunlin Zhang et al. · Science Immunology · 2024 · 45 citations · Full text

, , +17

Alternative splicing of its 5′-UTR limits CD20 mRNA translation and enables resistance to CD20-directed immunotherapies

Zhiwei Ang, Luca Paruzzo, Katharina E. Hayer et al. · Blood · 2023 · 44 citations · Full text

, , +17

1–5 of 13